Life Sciences
As the world emerges from the pandemic which has emphasised the critical importance of vaccination, Apiam Animal Health (ASX:AHX) has identified an opportunity to position Australia as leaders in autogenous vaccine manufacturing.
Apiam Animal Health Limited (ASX:AHX) has been at the forefront of animal health standards of care. But with one eye on their international counterparts, executives at Apiam foresee some major improvements in animal, customer and employee outcomes which will be driven by technology.
Invictus Ops Pty Ltd, a wholly owned subsidiary of NSX-listed VGI Health Technology Limited (NSX:VTL), is pleased to announce that it has contracted Resonance Health Ltd (ASX:RHT) to provide liver-fat quantification services for its clinical study on a potential new treatment for Non-Alcoholic Steatohepatitis.
Ladies and gentlemen, I am pleased to report that BTC Health Limited (ASX:BTC) has achieved a number of milestones over the past 12 months, including a greater penetration of our products within hospitals.
I am pleased to provide you with a detailed update on BTC Health Limited's (ASX:BTC) investments, along with an operational update of BTC's wholly owned investee companies.
The primary objective for BTC Speciality Health is to increase market share through organic growth. New products will continue to be sourced by BioImpact and will enable BTC Speciality Health to expand its product range within pain management and critical care.
Medlab Clinical Ltd (ASX:MDC), an Australian biotech using delivery platforms to enhance medicines is pleased to announce the execution of a Master Services Agreement with WEP Clinical Ltd for the exclusive development and delivery of Named Patient Programmes
BTC Health Limited (ASX:BTC) is pleased to announce its investee company, BioImpact Pty Ltd, has acquired exclusive distribution rights for specialty respiratory brands Bronchitol(R) and Aridol(R) from Pharmaxis (ASX:PXS) in Australia, New Zealand, Singapore, Malaysia, Hong Kong and South Korea (Bronchitol(R) only).
BTC Health Limited (ASX:BTC) is pleased to announce the receipt of binding firm commitments for a $2.5 million private placement to fund the acquisition of exclusive distribution rights to Bronchitol(R) and Aridol(R) in Australia, New Zealand, Malaysia, Hong Kong and Singapore.
Cortical is an Australian based medical device technology company that has developed an industry disruptive brain function monitor independently described as "a paradigm busting technology from an Australian based device house that really gives a significant advantage in this space".
Banking & Finance
- NSX Limited (ASX:NSX) Appointment of Managing Director and CEO - Max Cunningham
- ISX Financial EU PLC Announces Record-Breaking Q1 2024 Earnings
- NSX Limited (ASX:NSX) Quarterly Activities Report